According to a market report by Lucintel, the future of the global liquid biopsy market looks promising with opportunities in the reference laboratory, hospital & physician laboratory, and academic & research center markets. The global liquid biopsy market is expected to reach an estimated $12,387 million by 2035 with a CAGR of 7.4% from 2026 to 2035. The major drivers for this market are the increasing use of precision medicine is driving market expansion, the rising need for non-invasive diagnosis solution, and the growing use of liquid biopsy in treatment monitoring.
A more than 150-page report to understand trends, opportunity and forecast in liquid biopsy market to 2035 by product (assays kits, instruments, and services), circulating biomarker (circulating tumor cells, circulating tumor DNA, cell-free DNA, extracellular vesicles, and others), application (oncology and non-cancer), end use (reference laboratories, hospitals & physician laboratories, academic & research centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the product category, assay kit is expected to witness the highest growth over the forecast period.
Within the end use category, hospital & physician laboratory is expected to witness the highest growth.
Download sample by clicking on liquid biopsy market
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Bio-Rad Laboratories, QIAGEN, MDxHealth, Myriad Genetics, Biocept, Inc. , F. Hoffmann-La Roche Ltd. , Thermo Fisher Scientific Inc. , Illumina, Inc. , Cardiff Oncology, Guardant Health are the major suppliers in the liquid biopsy market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Office Fountain Pen Market
mPOS Device Market
Mobile POS Machine Market
Methyl Methacrylate Market
MEMS and Crystal Oscillator Market